Dr. Ahmed Kelani expressed his appreciation to Pharmadule, our Success Partner, for achieving the highest specifications. He noted that this success enhances new scopes for mutual cooperation between EIPICO and Pharmadule Morimatsu AB in future our projects.
On the other hand, Mrs. Helen Zhang expressed her happiness at the implementation of this project, extending her thanks to Dr. Ahmed Kelani and all of EIPICO 3 team. She praised their cooperation and professionalism, which contributed to the success of this important project, which is the first of their kind in Egypt.
EIPICO 3 factory is the first factory in Egypt and the Middle East to fully manufacture biosimilars and biologicals, starting from the cell line up to the finished product, passing through upstream and downstream processes. The products will be available in several forms, including vials. Ready-filled syringes, cartridges, as well as pens.
EIPICO 3 investment of $100 million, the facility is located on an area of 10,500 square meters in 10th of Ramadan City. It aims to provide a sustainable supply of the highest-quality, affordable medications for treating certain cancers and blood diseases.
This comply with the state's policy to localize the biopharmaceutical products and ensure its availability to the patients.